PACT-Kenya-header

KHA launches patient identification mobile app

In December, the Kenya Haemophilia Association (KHA) launched a patient identification mobile application as part of their participation in the WFH Path to Access to Care and Treatment (PACT) Program. The PACT Program is a 5-year initiative, designed to improve outreach and diagnosis and increase access to sustainable care for people with inherited bleeding disorders.

Also available in: Français Español

The application was launched on December 7, 2022 at the Nakuru Level 5 Hospital, during the opening of a new hemophilia treatment centre (HTC) in Nakuru County. The mobile app will contribute directly to one of the key PACT Program objectives of increasing the identification of people with bleeding disorders. Over eight hundred people are registered in Kenya with bleeding disorders. Through the app, the KHA seeks to increase this number to a total of at least one thousand. By using this new app, the KHA will be able to reach many more people than was previously possible—particularly in areas with high population densities. David Kones, the Deputy Governor of Nakuru County and the honourable Jacqualine Osoro, Country Executive Committee (CEC) member responsible for Health and Sanitation, were both present at the ceremony.

A pilot training was completed in the Tana River county, and consultations were held with the county government of Nairobi. The next step is to begin training users. As part of the outreach and diagnosis activities under the PACT Program, the KHA will offer training to the Community Health Volunteer (CHV) group’s core members on bleeding disorders essentials, and how to use the new mobile app to help identify new patients. CHV supervisors will in turn then train other members in their organization.

In addition to the support already provided for the development of the app, the PACT Program will help KHA carry out further training and outreach project activities across six Kenyan counties in 2023: Nairobi, Kisii, Muranga, Kakamega, Kilifi and Meru.

Everyone at the Kenya Haemophilia Association (KHA) is looking forward to using the app to identify new patients and bring care to thousands of people who currently might not even know they have a bleeding disorder.

To find out more about the WFH Path to Access to Care and Treatment (PACT) Program, please click here.

The PACT (Path to Access to Care and Treatment) Program is supported by funding from Roche, our visionary partner; CSL Behring, Pfizer and Sanofi Genzyme, our leadership partners; and Bayer, Biotest and Grifols, our collaborating partners. 

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.